Affordable Access

Publisher Website

Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors

Authors
Journal
American Journal of Hypertension
0895-7061
Publisher
Oxford University Press
Publication Date
Volume
16
Issue
2
Identifiers
DOI: 10.1016/s0895-7061(02)03203-x
Keywords
  • Original Contribution
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

Abstract Nonsteroidal anti-inflammatory drugs interfere with certain antihypertensive therapies. In a double-blind study, 385 hypertensive patients stabilized on an angiotensin converting enzyme inhibitor were treated with nabumetone, celecoxib, ibuprofen, or placebo for 4 weeks. Ibuprofen caused significantly greater increases in systolic ( P < .001) and diastolic ( P < .01) blood pressures (BPs) compared to placebo, but not nabumetone or celecoxib. The proportion of patients with systolic BP increases of clinical concern at end point was significantly higher ( P < .001) for the ibuprofen group (16.7%; 15 of 90), but not for the nabumetone group (5.5%; 5 of 91) or the celecoxib group (4.6%; 4 of 87) compared to the placebo group (1.1%; 1 of 91).

There are no comments yet on this publication. Be the first to share your thoughts.